COMMUNIQUÉS West-GlobeNewswire
-
Ashvattha Therapeutics to Showcase Topline Phase 2 Data and Recent FDA Alignment at Upcoming Investor and Ophthalmology Meetings
17/11/2025 -
Cytokinetics Supports American Heart Association Initiative to Improve Care for People Living With Hypertrophic Cardiomyopathy
17/11/2025 -
Halda Therapeutics Announces Acquisition by Johnson & Johnson
17/11/2025 -
INVO Fertility Announces Third Quarter 2025 Financial Results
17/11/2025 -
TOMI Environmental Solutions, Inc. Announces Filing of $50 Million Universal Shelf Registration Statement and Equity Line of Credit
17/11/2025 -
Veri Medtech (VRHI) Files Registration Statement for Proposed Initial Public Offering
17/11/2025 -
SeaStar Medical Announces Appointment of Michael Messinger as CFO
17/11/2025 -
Propanc Biopharma Provides Corporate Update and Reports First Quarter 2025/26 Results
17/11/2025 -
24/7 Market News- Kraig Labs’ Production Program Enters Critical Phase as Initial Spider Silk Deliveries Nears
17/11/2025 -
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
17/11/2025 -
Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee
17/11/2025 -
Lite Strategy Reports First Quarter Fiscal Year 2026 Results; Highlights Successful Launch of $100M Litecoin Treasury Strategy and Movement into Active Capital Market Operations
17/11/2025 -
JenaValve Announces 1,000th Case with the Trilogy™ Transcatheter Heart Valve (THV) System
17/11/2025 -
Ohio State’s Center for Psychedelic Drug Research and Education collaborates with MAPS for the Ohio P.E.A.C.E. program
17/11/2025 -
Corza Medical Launches SensorTek™ ROP Kit: The First and Only Single-Use Kit with Integrated Lens for Retinopathy of Prematurity Exams
17/11/2025 -
Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M
17/11/2025 -
Positron Corporation Announces Its Transition to a Reporting SEC Company
17/11/2025 -
FDA Grants Fast Track Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer
17/11/2025 -
Vital Nutrients Releases Clinical Findings Showing Plant-Based Cortisol Balance Improves Sleep, Mood, and Stress Response
17/11/2025
Pages